Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Elson

Showing results (11-20 of 55) with videos related to

Pageof 6
Sort By:
Investigational New Drugs|April 1, 1992
Trimetrexate in advanced renal cell carcinoma. An ECOG phase II trialR S Witte, P Elson, G T Bryan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1995
Importance of bleomycin in favorable-prognosis disseminated germ cell tumors: an Eastern Cooperative Oncology Group trialP J Loehrer, D Johnson, P Elson, et al.
Investigational New Drugs|January 1, 1996
A phase II trial of amonafide, caracemide, and homoharringtonine in the treatment of patients with advanced renal cell cancerR S Witte, P Hsieh, P Elson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Clinical features of hypersensitivity reactions to carboplatinM Markman, A Kennedy, K Webster, et al.
Journal of the American College of Surgeons|July 11, 1998
A prospective, randomized trial comparing laparoscopic versus conventional techniques in colorectal cancer surgery: a preliminary reportJ W Milsom, B Böhm, K A Hammerhofer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 22, 2010
Sunitinib and sorafenib in metastatic renal cell carcinoma patients with renal insufficiencyG Khan, A Golshayan, P Elson, et al.
American Journal of Clinical Oncology|March 10, 2001
Chemotherapy for acute myelogenous leukemia in the elderly with cytarabine, mitoxantrone, and granulocyte-macrophage colony-stimulating factorM Kalaycio, B Pohlman, P Elson, et al.
Investigational New Drugs|May 1, 1993
5-Azacytidine (NSC 102816) in refractory germ cell tumors. A phase II trial of the Eastern Cooperative Oncology GroupB J Roth, P Elson, G W Sledge, et al.
Investigational New Drugs|September 5, 2002
A phase I trial of weekly gemcitabine and subcutaneous interferon alpha in patients with refractory renal cell carcinomaF Perez-Zincer, T Olencki, G T Budd, et al.
Diseases of the Colon and Rectum|January 24, 2002
Prospective, randomized trial comparing laparoscopic vs. conventional surgery for refractory ileocolic Crohn's diseaseJ W Milsom, K A Hammerhofer, B Böhm, et al.
Pageof 6

Showing results (11-20 of 55) with videos related to

Sort By:
Pageof 6
Investigational New Drugs|April 1, 1992
Trimetrexate in advanced renal cell carcinoma. An ECOG phase II trialR S Witte, P Elson, G T Bryan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1995
Importance of bleomycin in favorable-prognosis disseminated germ cell tumors: an Eastern Cooperative Oncology Group trialP J Loehrer, D Johnson, P Elson, et al.
Investigational New Drugs|January 1, 1996
A phase II trial of amonafide, caracemide, and homoharringtonine in the treatment of patients with advanced renal cell cancerR S Witte, P Hsieh, P Elson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Clinical features of hypersensitivity reactions to carboplatinM Markman, A Kennedy, K Webster, et al.
Journal of the American College of Surgeons|July 11, 1998
A prospective, randomized trial comparing laparoscopic versus conventional techniques in colorectal cancer surgery: a preliminary reportJ W Milsom, B Böhm, K A Hammerhofer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 22, 2010
Sunitinib and sorafenib in metastatic renal cell carcinoma patients with renal insufficiencyG Khan, A Golshayan, P Elson, et al.
American Journal of Clinical Oncology|March 10, 2001
Chemotherapy for acute myelogenous leukemia in the elderly with cytarabine, mitoxantrone, and granulocyte-macrophage colony-stimulating factorM Kalaycio, B Pohlman, P Elson, et al.
Investigational New Drugs|May 1, 1993
5-Azacytidine (NSC 102816) in refractory germ cell tumors. A phase II trial of the Eastern Cooperative Oncology GroupB J Roth, P Elson, G W Sledge, et al.
Investigational New Drugs|September 5, 2002
A phase I trial of weekly gemcitabine and subcutaneous interferon alpha in patients with refractory renal cell carcinomaF Perez-Zincer, T Olencki, G T Budd, et al.
Diseases of the Colon and Rectum|January 24, 2002
Prospective, randomized trial comparing laparoscopic vs. conventional surgery for refractory ileocolic Crohn's diseaseJ W Milsom, K A Hammerhofer, B Böhm, et al.
Pageof 6